NCT04837235View on ClinicalTrials.gov

Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of Hemay005 In Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

April 29, 2021

Primary Completion Date

August 1, 2021

Study Completion Date

August 25, 2021

Conditions

Psoriasis

Interventions

DRUG

Hemay005

oral

Trial Locations (1)

Unknown

Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou

All Listed Sponsors

lead

Tianjin Hemay Pharmaceutical Co., Ltd

INDUSTRY